Planning Capital Management Corporation’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Planning Capital Management Corporation’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-320	Closed	-$730	–	922
2024 Q2	$730	Buy	+320	New	+$1.22K	﹤0.01%	603

Planning Capital Management Corporation's GTHX Position: Q3 2024 in Review

Planning Capital Management Corporation sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 320 shares — an estimated $730 sold.

Planning Capital Management Corporation first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $730 in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Planning Capital Management Corporation reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Planning Capital Management Corporation sold 320 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $730.
Planning Capital Management Corporation first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Planning Capital Management Corporation's G1 Therapeutics, Inc. Common Stock position peaked at $730 in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.